April 2016 DEAL SUMMARY Chartwell is pleased to announce Urschel Laboratories, Inc. (Urschel) has completed a 100% sale of the company’s equity to its employees through a newly established Employee Stock Ownership Plan (ESOP). The shareholders elected to sell to an ESOP to preserve Urschel's legacy and culture, and to reward the company’s employees for their past, current, and future service. The transaction successfully closed on February 29, 2016. CLIENT VALUE ADD "Our timeline was very aggressive, and the team at Chartwell had a short time frame to put together a very large, multiple-step, and highly complex transaction. From the Urschel company perspective, since this was the only ESOP transaction we've ever been a part of, we were unaware of the amount of work required to bring all the puzzle pieces together. The Chartwell team made navigating these waters seem routine. They expertly assisted with everything from negotiating with the capital providers and the ESOP trustee to offering guidance in presenting the plan to the shareholders and revealing the ESOP to the employees. Reflecting on the amount of work that Chartwell did for us in such a short time frame truly puts them in the top-tier of firms we've dealt with over our 106-year history.” Rick UrschelCEOUrschel Laboratories, Inc. ABOUT URSCHEL LABORATORIES, INC. Urschel Laboratories, Inc. was founded in 1910 by William Urschel and was owned and operated by the Urschel family for four generations. Urschel is a global leader in food-cutting equipment and one of the world's largest producers of size reduction equipment. The company is based in Chesterton, Indiana with sales offices in Europe, Asia, and South America. For more information about Urschel, please visit www.urschel.com. ABOUT CHARTWELL FINANCIAL ADVISORY Chartwell provides comprehensive financial advisory solutions and investment banking services to the middle market. With substantial corporate finance and capital markets expertise, the Chartwell team works with clients and their advisors to deliver independent, solutions-based advisory services that are unbiased to outcome, free from conflicts, and focus on optimizing client objectives. For more information about Chartwell, please visit www.chartwellfa.com. For additional information on this transaction, please contact Greg Fresh at 612-230-3125 or email@example.com or Will Bloom at 312-803-4820 or firstname.lastname@example.org.